- In this population-based study, we used the most recent International Agency for Research on Cancer (IARC) monograph on personal habits to select cancer types with sufficient evidence of a causal relationship with the consumption of alcoholic beverages
- The study found that 4.1% or 741,300 new cases of cancer in 2020 we attributed to moderate to heavy alcohol consumption
- The study was carried out to highlight the need for effective policy and interventions as well as increased awareness of cancer risks associated with alcohol consumption
to learn more.
SVMPharma is an innovative strategic consultancy and CRO, with a focus in Real World Evidence (RWE) for pharmaceutical and biotechnology companies. SVMPharma delivers clinical trials within UK and Europe.
DISTILL is a new EDC launched by SVMPharma. As a CRO discover the benefits of DISTILL as part of your service offering and take back control of your clinical trials. DISTILL allows you to develop and manage every aspect of your trials from start to finish. Move away from the restrictions and costs associated with legacy systems.
For more information, please visit www.svmpharma.com
and contact us at email@example.com